Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.073 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |